Released Fall 2019
Employers are approaching a critical inflection point in their cancer benefit design, which will inevitably lead to changes in the oncology market environment for biopharmaceutical manufacturers (biopharma).
The Oncology Management & Benefit Design report identifies the role and opportunities for biopharma to engage in defining sustainable cancer management solutions, and ultimately make their case for ongoing product access and appropriate reimbursement.
Subscribers can use this research to gain further understanding of how employers are managing the complexities of oncology care and to tailor their value proposition and support materials to resonate with employers.
A purchase of the Oncology Management and Benefit Design Report includes:
Contact Sarah Daley at 314-656-2384 for pricing, packages and additional details.